Breaking News Instant updates and real-time market news.

SNY

Sanofi

09:29
10/12/16
10/12
09:29
10/12/16
09:29

Sanofi revises down 3Q15 sales to EUR 9.46B from EUR 9.59B previously

Sanofi, following the announcement of exclusive negotiations with Boehringer Ingelheim and as an IFRS presentation requirement for discontinued operations, said that net income for Sanofi's Animal Health business, Merial, is reported on a separate line in the Consolidated Income Statement. Sanofi will continue to manage and report the performance of the Animal Health business, which will remain an operating segment until the closing of the transaction. On June 27, the signing of contracts to secure the transaction was announced. Sanofi now reports 3Q15 aggregate sales of EUR 9.455B, which excludes EUR 136M of VaxServe sales of products from other vaccine manufacturers.

  • 30

    Oct

  • 29

    Mar

SNY Sanofi

09/09/16
LEER
09/09/16
NO CHANGE
LEER
Leerink updates therapeutics best ideas for 2016
In a note to investors this morning, Leerink has updated its best ideas for 2016 from the firm's five therapeutics analysts. The list includes Alexion (ALXN), Dermira (DERM), Intra-Cellular (ITCI), Sanofi (SNY), Allergan (AGN), Alnylam (ALNY), Innate Pharma (IPHYF), The Medicines Co. (MDCO), and Ophthotech (OPHT).
09/13/16
EXAN
09/13/16
UPGRADE
EXAN
Neutral
Sanofi upgraded to Neutral from Underperform at Exane BNP Paribas
09/23/16
PIPR
09/23/16
INITIATION
PIPR
Neutral
Sanofi initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Richard Purkiss started Sanofi with a Neutral rating and EUR 76 price target.
10/03/16
ROTH
10/03/16
NO CHANGE
Target $520
ROTH
Buy
Regeneron has 'solid' growth prospects, upside potential, says Roth Capital
After Regeneron (REGN) and Sanofi (SNY) released positive results from their Dupixent Phase 3 trials, SOLO 1 and SOLO in patients with atopic dermatitis, Roth Capital analyst Joseph Pantginis notes that clinical studies of Dupixent for additional atopic and allergic diseases are progressing and says he believes Regeneron's shares are poised for upside on upcoming catalysts. Moreover, the analyst says Regeneron has "solid" growth prospects based on approved and late stage products, deep pipeline, expansion of indications for current products, strong partners, and strong cash management. He reiterates a Buy rating and $520 price target on Regeneron's shares.

TODAY'S FREE FLY STORIES

IJR

iShares Core S&P Small Cap ETF

$78.91

-0.65 (-0.82%)

06:42
01/19/18
01/19
06:42
01/19/18
06:42
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$50.03

0.06 (0.12%)

06:41
01/19/18
01/19
06:41
01/19/18
06:41
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APPN

Appian

$36.15

-2.28 (-5.93%)

06:41
01/19/18
01/19
06:41
01/19/18
06:41
Downgrade
Appian rating change  »

Appian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EWW

iShares MSCI Mexico

$52.62

0.38 (0.73%)

06:41
01/19/18
01/19
06:41
01/19/18
06:41
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:40
01/19/18
01/19
06:40
01/19/18
06:40
Hot Stocks
Synchrony CEO: Substantial progress made on strategic priorities »

"Substantial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

UUP

PowerShares DB US Dollar Index Up

$23.61

-0.03 (-0.13%)

06:40
01/19/18
01/19
06:40
01/19/18
06:40
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$116.41

-2.75 (-2.31%)

06:40
01/19/18
01/19
06:40
01/19/18
06:40
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

NOV

National Oilwell

$37.91

-1.01 (-2.60%)

06:40
01/19/18
01/19
06:40
01/19/18
06:40
Hot Stocks
National Oilwell sees Q4 results at or above prior expectations »

National Oilwell Varco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

UDN

PowerShares DB US Dollar Index Down

$22.78

0.03 (0.13%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Hot Stocks
Synchrony reports Q4 net interest margin 16.24% compared to 16.26% last year »

Return on assets was 1.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PB

Prosperity Bancshares

$74.26

-0.2 (-0.27%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Prosperity Bancshares announces stock repurchase program »

Prosperity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 30

    Jan

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

, BIIB

Biogen

$344.44

-0.43 (-0.12%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Periodicals
Biogen among companies weighing bids for Acorda, Bloomberg reports »

Biogen (BIIB) and…

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

BIIB

Biogen

$344.44

-0.43 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Mar

SYF

Synchrony

$37.31

-0.75 (-1.97%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Synchrony reports estimated Common Equity Tier 1 ratio 16% »

The estimated Common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MRK

Merck

$61.13

-0.9 (-1.45%)

, AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Merck, AstraZeneca: LYNPARZA receives approval in Japan »

AstraZeneca (AZN) and…

MRK

Merck

$61.13

-0.9 (-1.45%)

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

GWR

Genesee & Wyoming

$81.57

0.18 (0.22%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Genesee & Wyoming reports December traffic 255,199 carloads, down 5,7% y/y »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Hot Stocks
Synchrony reports Q4 net interest income up 8% to $3.9B »

Loan receivables grew $6…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FHN

First Horizon

$20.21

-0.09 (-0.44%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Earnings
First Horizon reports Q4 EPS (20c) may not compare with consensus 30c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Periodicals
AstraZeneca sees big productivity jump amid fewer drug projects, Reuters reports »

AstraZeneca has seen an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

  • 08

    Mar

  • 23

    Apr

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Breaking Earnings news story on Wipro »

Wipro sees Q4 IT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Wipro reports Q3 revenue $2.1B, consensus $2.1B »

IT Services Segment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Hot Stocks
Breaking Hot Stocks news story on Citizens Financial »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

JAPAF

Japan Tobacco

$32.91

-0.29 (-0.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Upgrade
Japan Tobacco rating change  »

Japan Tobacco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:32
01/19/18
01/19
06:32
01/19/18
06:32
Hot Stocks
Citizens Financial raises quarterly dividend 22% to 22c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

PM

Philip Morris

$105.07

-0.72 (-0.68%)

, MO

Altria Group

$70.03

-0.12 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Upgrade
Philip Morris, Altria Group, British American Tobacco rating change  »

Philip Morris upgraded to…

PM

Philip Morris

$105.07

-0.72 (-0.68%)

MO

Altria Group

$70.03

-0.12 (-0.17%)

BTI

British American Tobacco

$68.56

-0.82 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Earnings
Citizens Financial reports Q4 EPS $1.35 with items, consensus 67c »

Reports Q4 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.